Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • National Major Science and Technology Projects of China (2012ZX10002001, 2018ZX10721202)
  • National Science and Technology Major Project (2012ZX10002001, 2018ZX10721202)

This publication has 21 references indexed in Scilit: